Successful investors make money by preparing for scenarios without letting their politics cloud their judgement. That’s a difficult task, especially in these partisan times. But I am politically agnostic, and I see my job as helping other investors. The chart To understand the new development today, let us look at
This post was just published on ZYX Buy Change Alert. FOLD plans to submit a new drug application to FDA for the oral precision medicine migalastat for Fabry disease. The stock is jumping on the news. We are not recommending buying FOLD here but it can be part of a basket on
This post was just published on ZYX Buy Change Alert. New buy zone for those not in ARNA is $20.33 to $22.78. Maximum position is 20% of the full core position size. New target zone without a buyout is $32 to $34. In the event of a buyout, a price in the
This post was published on ZYX Buy Change Alert. ARNA is long from $16.20. It is trading at $25 as of this writing. The company announced positive Phase 2 results for Ralinepag for the treatment of pulmonary arterial hypertension. The gains are not as some are mistakenly thinking. The stock was